The covid 19 boosters have been making headlines for a while now. Not too long ago, we revealed that experts are criticizing the Biden administration’s push to widely distribute Covid 19 vaccine boosters in the US for the next month.
They are claiming that the data provided by the federal health officials this week is not compelling enough to recommend third shots to most of the American population.
CNBC noted not too long ago that U.S. health leaders say they are preparing to offer booster shots to all eligible Americans beginning the week of Sept. 20.
Covid 19 boosters are more complicated than they seem
Now, it’s been just revealed that not everyone agrees that the booster shots against the novel covid vaccines are necessary for all Americans.
It’s also been revealed that this debate could be slowing down the process of rolling out extra doses of the mRNA vaccines later this month, and it could also change who is eligible for them.
Dr. Sara Oliver, a Centers for Disease Control and Prevention official who leads the COVID-19 vaccines workgroup, said the following:
“priority for booster dose policy should be the prevention of severe disease in at-risk populations.”
She cited nursing-home residents and frontline healthcare workers as examples.
MarketWatch also reported that the U.S. regulators have yet to OK a booster dose for the general public. It’s also important to note the fact that this has become a point of contention for some public health experts.
The Biden administration’s announcement has the following effect:
It “led everyone — it led physicians, it led the public — to believe that they had access to information about these vaccines and the need for boosters that had not yet been publicly released.”
This is what Dr. Sandra Adamson Fryhofer, an adjunct associate professor of medicine at Emory University School of Medicine, said Monday.
“To me, that opened the door to a lot of confusion.”
Stay tuned for more news about the novel coronavirus and potential treatments/viable vaccines.
